EA200800147A1 - Способ получения олмесартан медоксомила - Google Patents

Способ получения олмесартан медоксомила

Info

Publication number
EA200800147A1
EA200800147A1 EA200800147A EA200800147A EA200800147A1 EA 200800147 A1 EA200800147 A1 EA 200800147A1 EA 200800147 A EA200800147 A EA 200800147A EA 200800147 A EA200800147 A EA 200800147A EA 200800147 A1 EA200800147 A1 EA 200800147A1
Authority
EA
Eurasian Patent Office
Prior art keywords
olmesartan
medoksomil
obtaining
hypertension
medicament
Prior art date
Application number
EA200800147A
Other languages
English (en)
Other versions
EA014026B1 (ru
Inventor
Сильво Зупанциц
Аница Пецавар
Миха Врбинц
Рената Осольник
Original Assignee
Крка, Товарна Здравил, Д. Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200500221A external-priority patent/SI22092A/sl
Priority claimed from EP06002388A external-priority patent/EP1816131A1/en
Application filed by Крка, Товарна Здравил, Д. Д., Ново Место filed Critical Крка, Товарна Здравил, Д. Д., Ново Место
Publication of EA200800147A1 publication Critical patent/EA200800147A1/ru
Publication of EA014026B1 publication Critical patent/EA014026B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

Настоящее изобретение относится к улучшенному способу получения олмесартана и его фармацевтически приемлемых солей и эфиров в качестве активного ингредиента лекарственного средства для лечения гипертонии и связанных с ней болезней и состояний.
EA200800147A 2005-07-29 2006-07-27 Способ получения олмесартан медоксомила EA014026B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200500221A SI22092A (sl) 2005-07-29 2005-07-29 Postopek za pripravo olmesartan medoksomila
EP06002388A EP1816131A1 (en) 2006-02-06 2006-02-06 Process for the preparation of olmesartan medoxomil
PCT/EP2006/007453 WO2007017135A2 (en) 2005-07-29 2006-07-27 Process for the preparation of olmesartan medoxomil

Publications (2)

Publication Number Publication Date
EA200800147A1 true EA200800147A1 (ru) 2008-06-30
EA014026B1 EA014026B1 (ru) 2010-08-30

Family

ID=36979539

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800147A EA014026B1 (ru) 2005-07-29 2006-07-27 Способ получения олмесартан медоксомила

Country Status (5)

Country Link
US (1) US7943779B2 (ru)
EP (1) EP1910343B1 (ru)
CA (1) CA2616466A1 (ru)
EA (1) EA014026B1 (ru)
WO (1) WO2007017135A2 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801111B1 (en) * 2005-12-20 2014-07-16 LEK Pharmaceuticals d.d. Novel polymorph forms of olmesartan medoxomil
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil
WO2007148344A2 (en) * 2006-06-19 2007-12-27 Matrix Laboratories Limited Process for the preparation of olmesartan medoxomil
KR101458369B1 (ko) * 2006-10-09 2014-11-05 씨아이피엘에이 엘티디. 트리틸 올메사탄 메독소밀 및 올메사탄 메독소밀의 제조방법
CA2681591A1 (en) * 2007-03-23 2008-10-02 Daiichi Sankyo Company, Limited Pulverized crystals of olmesartan medoxomil
CN101311168B (zh) * 2007-05-21 2010-12-08 上海医药工业研究院 4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸酯的制备方法
GB0710680D0 (en) * 2007-06-05 2007-07-11 Generics Uk Ltd Novel crystalline form of olmesartan medoxmil
GB0710905D0 (en) * 2007-06-07 2007-07-18 Generics Uk Ltd Amorphous olmesartan medoxomil
EP2022790A1 (en) * 2007-08-08 2009-02-11 LEK Pharmaceuticals D.D. A process for the preparation or purification of olmesartan medoxomil
CA2707365A1 (en) 2007-08-08 2009-02-12 Lek Pharmaceuticals D.D. A process for the preparation of olmesartan medoxomil
EP2036904A1 (en) * 2007-08-08 2009-03-18 LEK Pharmaceuticals D.D. A process for the preparation of olmesartan medoxomil
CN102083823B (zh) 2008-06-09 2015-10-07 第一三共株式会社 1-联苯甲基咪唑化合物的制备方法
MY158090A (en) 2009-04-28 2016-08-30 Daiichi Sankyo Co Ltd Novel solvate crystals
ES2527686T3 (es) 2009-04-28 2015-01-28 Daiichi Sankyo Company, Limited Procedimiento de producción de olmesartán medoxomil
WO2011007368A2 (en) 2009-07-14 2011-01-20 Cadila Healthcare Limited An improved process for preparation of olmesartan
WO2011014611A2 (en) * 2009-07-30 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of olmesartan medoxomil
WO2011083112A2 (en) 2010-01-05 2011-07-14 Ratiopharm Gmbh Solid oral dosage form containing olmesartan medoxomil
AR083523A1 (es) 2010-10-29 2013-03-06 Interquim Sa Procedimiento de obtencion del olmesartan medoxomilo
MX2014001298A (es) * 2011-08-05 2014-09-01 Lupin Ltd Procedimiento para la preparacion de olmesartan medoxomilo.
CN102351849B (zh) * 2011-10-26 2013-10-02 齐鲁天和惠世制药有限公司 一种奥美沙坦酯的制备方法
US20150225380A1 (en) 2012-08-22 2015-08-13 Lupin Limited Novel Method to Obtain Olmesartan Medoxomil With Reduced Particle Size
KR101418871B1 (ko) * 2012-08-28 2014-07-17 한국과학기술연구원 올메사탄 메독소밀의 정제방법
US10835714B2 (en) 2016-03-21 2020-11-17 Edwards Lifesciences Corporation Multi-direction steerable handles for steering catheters
US10973638B2 (en) 2016-07-07 2021-04-13 Edwards Lifesciences Corporation Device and method for treating vascular insufficiency
US11224511B2 (en) 2017-04-18 2022-01-18 Edwards Lifesciences Corporation Heart valve sealing devices and delivery devices therefor
CN107311990B (zh) * 2017-07-25 2021-09-03 浙江华海致诚药业有限公司 一种奥美沙坦酯的制备方法
US10105222B1 (en) 2018-01-09 2018-10-23 Edwards Lifesciences Corporation Native valve repair devices and procedures
US10945844B2 (en) 2018-10-10 2021-03-16 Edwards Lifesciences Corporation Heart valve sealing devices and delivery devices therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920540A1 (en) * 1991-02-21 1992-08-26 Sankyo Co 1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
ATE194603T1 (de) * 1994-01-28 2000-07-15 Takeda Chemical Industries Ltd Ein verfahren zur herstellung von tetrazolyl- verbindungen
JP3671266B2 (ja) 1996-03-21 2005-07-13 東洋化成工業株式会社 ５−置換テトラゾール類の製造方法
CN1197866C (zh) 2003-03-21 2005-04-20 上海医药工业研究院 4，6－二氢呋喃并[3,4－d]咪唑－6－酮衍生物及其盐和制备方法
CN1271068C (zh) 2003-03-25 2006-08-23 上海医药工业研究院 一种奥美沙坦酯的制备方法
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.
CN1976926A (zh) 2004-09-02 2007-06-06 特瓦制药工业有限公司 奥美沙坦酯的制备

Also Published As

Publication number Publication date
EA014026B1 (ru) 2010-08-30
EP1910343A2 (en) 2008-04-16
WO2007017135A3 (en) 2007-04-12
US7943779B2 (en) 2011-05-17
EP1910343B1 (en) 2014-10-29
US20090131680A1 (en) 2009-05-21
WO2007017135A2 (en) 2007-02-15
CA2616466A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
EA200800147A1 (ru) Способ получения олмесартан медоксомила
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201200763A1 (ru) Замещенные производные карбамоилметиламиноуксусной кислоты в качестве новых ингибиторов nep
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
EA201790653A1 (ru) Способ лечения болезни альцгеймера и других расстройств
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
EA201101507A1 (ru) Способы лечения солидных опухолей
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA201500432A1 (ru) Соединения боронатного эфира и его фармацевтические составы
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
WO2009109654A8 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1
ATE528309T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
EA201270747A1 (ru) Композиции и способы для профилактики и лечения ран
EA200800706A1 (ru) Способ приготовления кандесартана цилексетила
PE20110391A1 (es) Polimorfos de la sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina
WO2006133231A3 (en) Treatment for neurodegenerative diseases

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM